Marion Delphin

Marion Delphin


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 December 2021 in Viruses
Verified
Journal Article
Open access
PDF file
MDMarion Delphin
Marion Delphin
SFSUZANNE FAURE-DUPUY
SUZANNE FAURE-DUPUY
NINathalie Isorce
Nathalie Isorce
MRMichel Rivoire
Michel Rivoire
ASAnna Salvetti
Anna Salvetti
Julie LuciforaJulie Lucifora
Julie Lucifora
Co-infection with the hepatitis B virus and hepatitis delta virus (HDV) leads to the most aggressive form of viral hepatitis. Using in vitro infection models, we confirmed that IL-1β, a crucial innate immune molecule for pathogen control, was very potent against HBV from different genotypes. Additionally, we demonstrated for the first time a strong and rapid antiviral effect induced by very low doses of IL-1β against HDV. In parallel, using co-culture assays, we demonstrated that monocytes exposed to HBV, and in particular to HBsAg, during differentiation into pro-inflammatory macrophages secreted less IL-1β. Altogether, our data emphasize the importance of developing combined antiviral strategies that would, for instance, reduce the secretion of HBsAg and stimulate the immune system to produce endogenous IL-1β efficient against both HBV and HDV.